Sanhoc Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-05-2024
- Paid Up Capital ₹ 1.50 M
as on 29-05-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -47.42%
(FY 2022)
- Profit -132.00%
(FY 2022)
- Ebitda -98.00%
(FY 2022)
- Net Worth -35.30%
(FY 2022)
- Total Assets -22.55%
(FY 2022)
About Sanhoc Labs
The Corporate was formerly known as Shre Pharma Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Marthy, Srinivas Sistla, and Tamilmani Shanmugam serve as directors at the Company.
- CIN/LLPIN
U24232TG2011PLC076052
- Company No.
076052
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sanhoc Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tamilmani Shanmugam  | Director | 30-Apr-2016 | Current |
| Venkata Marthy | Director | 30-Apr-2016 | Current |
| Srinivas Sistla | Director | 19-Jul-2018 | Current |
Financial Performance and Corporate Structure Insights of Sanhoc Labs.
Sanhoc Labs Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 47.42% decrease. The company also saw a substantial fall in profitability, with a 132% decrease in profit. The company's net worth observed a substantial decline by a decrease of 35.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanhoc Labs?
In 2020, Sanhoc Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Veritaz Healthcare LimitedActive 18 years 3 monthsVenkata Marthy and Srinivas Sistla are mutual person
Sportz & Live Entertainment Private LimitedActive 10 years 5 monthsSrinivas Sistla is a mutual person
Chrogene Aarogyam Biotech Private LimitedActive 7 years 2 monthsTamilmani Shanmugam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanhoc Labs?
Unlock and access historical data on people associated with Sanhoc Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanhoc Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanhoc Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
